Clinical Trial Update: PROMMO Trial: Oral Misoprostol vs IV Oxytocin [EARLY_Phase 1]

View source ↗

Summary

The study is a completed early-phase 1 trial comparing oral misoprostol with IV oxytocin for management of premature rupture of membranes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Rupture of Membranes

Drugs mentioned

• Cytotec (misoprostol) (misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Premature Rupture of Membrane, Induction of Labor Affected Fetus / Newborn | EARLY_Phase 1 | Status: COMPLETED